Laughing rats are optimistic.Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in miceAntidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitorHuman opiorphin: the lack of physiological dependence, tolerance to antinociceptive effects and abuse liability in laboratory miceThe putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complexCharacterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic painPotential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal modelsEffects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats.The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats.Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in ratsCognitive effects of Colostral-Val nonapeptide in aged rats.2-MPPA, a selective glutamate carboxypeptidase II inhibitor, attenuates morphine tolerance but not dependence in C57/Bl mice.Brain levels of dextromethorphan and the intensity of opioid withdrawal in mice.Neurohypophyseal peptides and social recognition in rats.Preclinical pharmacology of citalopram.In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists.Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor.Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders.The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.Chronic psychosocial stress makes rats more 'pessimistic' in the ambiguous-cue interpretation paradigm.Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice.Memantine reduces consumption of highly palatable food in a rat model of binge eatingAntidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor.The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia.Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests.Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677.Enhancement of antidepressant-like effects but not brain-derived neurotrophic factor mRNA expression by the novel N-methyl-D-aspartate receptor antagonist neramexane in mice.The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.The effects of NMDA receptor antagonists on acute morphine antinociception in mice.Cognitive judgment bias in the psychostimulant-induced model of mania in rats.Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram.Effects of optimism on motivation in rats."Broad spectrum" antidepressants: is more better for the treatment of depression?Acute administration of lithium, but not valproate, modulates cognitive judgment bias in rats.Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in ratsN1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like PropertiesAdenosine A3 receptor stimulation and cerebral ischemiaPro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptorGlutamate-based antidepressants: 20 years on.
P50
Q21090823-B62308EC-873A-413E-AA57-676AAAA06281Q24674933-79A81DC4-EDA1-4A6A-A294-3BF9EB848B68Q28209288-88358B15-3CE9-4C81-8069-16F8488765B1Q28281194-B48B752F-97B5-4C24-A4B4-D56C8903501CQ28287426-5DD91291-388D-4FBF-8703-BF75C46622F8Q28290309-6E1DF1B4-A276-45AB-B4AE-60210884A09DQ28377976-FCE690A0-16A0-4964-B9E0-313AD8B8B090Q28533794-7DC81099-8F3F-450D-B5DC-71EA8ACAA1ADQ29398563-1DDEA932-00BA-4E56-9ABA-B3C02E555F5FQ30418172-1A9F462E-F459-4392-AA04-E895DDE3EA2BQ30444469-C6E76C19-8B04-4F74-A4B0-70D578B84C16Q31870128-9F09F71A-950B-49FF-A25C-7F17F97A7AEEQ33225041-29CFECD7-459B-414C-A71C-DBA9EE1BF8E1Q33323106-688485AE-50ED-479C-BAB0-75DA5007893CQ33540667-C02AED8D-460B-43BC-AD80-13C271870F93Q33744286-B29D4935-71C2-4BCC-945B-1C016A6172F3Q33856557-EF1B0E0A-A3B7-46D9-8A89-D8BEC1DBBAD6Q33999301-B27FC148-4855-407B-9B94-812A291DEE20Q34075093-EDE2C7DD-FDBA-478A-9036-7FEF3A5B3DFEQ34087393-F9D84E55-DE90-408E-97CB-B52C479FE926Q34367817-3EA2DA9D-7A09-4DA0-9A09-6CAC2891D53DQ34467792-32AA4D41-403B-4733-B96C-CA65EA96BC71Q34486676-9DA9C1DA-4B8A-46DA-9989-F9E399A2BBBAQ34488146-1967DFF9-D9A8-4E55-B304-7DF93ED5F3F2Q34488146-3BAFC95E-466F-49A0-BE4F-506A1C589FF2Q34511471-E579607D-7925-48A3-9203-2F68B4B6E9C9Q34516240-C3B31FB2-B2A0-4D6F-8D62-A42E51F53167Q34517414-44BEEC8C-15D6-4AAA-AB90-63BA46C2F169Q34532951-05F562E3-5F07-4046-9972-D0BE179640C3Q34565964-5CA6A9E3-C61E-453E-B81D-04FBDD727AA8Q34954431-AC4AD6C5-939C-4475-995C-283BC3CDBD87Q34996750-78CD1932-3A8E-4DBB-B80B-5060E1C28CA9Q35045542-528AAA59-768A-4614-8697-C3E403B02460Q35120636-C0671FB3-0C32-4700-AB99-ED1CCDEC3D63Q35560846-1BD26824-4021-4E72-8603-5044228F80EEQ35607547-76C36653-6EAA-4F6F-B626-0C736DD29D6CQ35748684-324934D2-508A-4C99-86BA-11328558CF6AQ36057491-115DFB22-E777-4028-9B2F-624745149B7AQ36185246-E6E831DE-340B-4AC4-8B9A-12F88FDB67F1Q36394997-86E87EA0-AD5A-49CD-9594-37D8B5F2B983
P50
description
Polnische Neuropsychopharmakologie
@de
chercheur polonais
@fr
investigador
@es
neuropsychopharmacologist from Poland
@en
polski neuropsychofarmakolog
@pl
研究者
@zh
name
Piotr Popik
@ast
Piotr Popik
@en
Piotr Popik
@es
Piotr Popik
@fr
Piotr Popik
@ga
Piotr Popik
@it
Piotr Popik
@nl
Piotr Popik
@pl
Piotr Popik
@sl
Piotr Popik
@sq
type
label
Piotr Popik
@ast
Piotr Popik
@en
Piotr Popik
@es
Piotr Popik
@fr
Piotr Popik
@ga
Piotr Popik
@it
Piotr Popik
@nl
Piotr Popik
@pl
Piotr Popik
@sl
Piotr Popik
@sq
altLabel
Piotr Iwo Popik
@pl
prefLabel
Piotr Popik
@ast
Piotr Popik
@en
Piotr Popik
@es
Piotr Popik
@fr
Piotr Popik
@ga
Piotr Popik
@it
Piotr Popik
@nl
Piotr Popik
@pl
Piotr Popik
@sl
Piotr Popik
@sq
P106
P1006
P214
P1006
P1153
7004710966
P1559
Piotr Popik
@pl
P21
P214
P2381
P27
P31
P3124
P496
0000-0003-0722-1263
0000-0003-3974-8553
P551
P569
1962-11-18T00:00:00Z
P734
P7859
viaf-288811509